China Addiction Treatment Market – Pharmaceutical Innovation in Anti-Craving and Substitution Therapies
Market Overview China's domestic pharmaceutical industry is accelerating development of addiction pharmacotherapies, historically dependent on imported methadone and limited buprenorphine supply. Government research funding and regulatory priority pathways now support domestic development of anti-craving agents, long-acting formulations, and novel mechanisms targeting dopamine pathways....
0 Commentaires 0 Parts 40 Vue 0 Aperçu
SocioMint https://sociomint.com